Literature DB >> 18539112

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Jing Yang1, Robert A Weinberg.   

Abstract

The epithelial-mesenchymal transition is a highly conserved cellular program that allows polarized, immotile epithelial cells to convert to motile mesenchymal cells. This important process was initially recognized during several critical stages of embryonic development and has more recently been implicated in promoting carcinoma invasion and metastasis. In this review, we summarize and compare major signaling pathways that regulate the epithelial-mesenchymal transitions during both development and tumor metastasis. Studies in both fields are critical for our molecular understanding of cell migration and morphogenesis.

Entities:  

Mesh:

Year:  2008        PMID: 18539112     DOI: 10.1016/j.devcel.2008.05.009

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  1330 in total

1.  Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement.

Authors:  Rebecca A Whipple; Michael A Matrone; Edward H Cho; Eric M Balzer; Michele I Vitolo; Jennifer R Yoon; Olga B Ioffe; Kimberly C Tuttle; Jing Yang; Stuart S Martin
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.

Authors:  Runlin Shi; Haibing Xiao; Tao Yang; Lei Chang; Yuanfeng Tian; Bolin Wu; Hua Xu
Journal:  Front Med       Date:  2014-11-03       Impact factor: 4.592

3.  Establishment of a New Ovarian Cancer Cell Line CA5171.

Authors:  Ying-Cheng Chiang; Wen-Fang Cheng; Ming-Cheng Chang; Tzu-Pin Lu; Kuan-Ting Kuo; Hsiu-Ping Lin; Chang-Yao Hsieh; Chi-An Chen
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

4.  MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis.

Authors:  Stephen R Filios; Guanlan Xu; Junqin Chen; Kyunghee Hong; Gu Jing; Anath Shalev
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

5.  Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT).

Authors:  Laurence Blavier; Alisa Lazaryev; Xiang-He Shi; Frederick J Dorey; Gregory M Shackleford; Yves A DeClerck
Journal:  Cancer Biol Ther       Date:  2010-07-29       Impact factor: 4.742

6.  Circular RNA Vav3 sponges gga-miR-375 to promote epithelial-mesenchymal transition.

Authors:  Xinheng Zhang; Yiming Yan; Wencheng Lin; Aijun Li; Huanmin Zhang; Xiaoya Lei; Zhenkai Dai; Xinjian Li; Hongxin Li; Weiguo Chen; Feng Chen; Jingyun Ma; Qingmei Xie
Journal:  RNA Biol       Date:  2019-01-15       Impact factor: 4.652

7.  Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling.

Authors:  Pang-Kuo Lo; Yongshu Zhang; Yuan Yao; Benjamin Wolfson; Justine Yu; Shu-Yan Han; Nadire Duru; Qun Zhou
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

8.  Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy.

Authors:  Christelle P El-Haibi; George W Bell; Jiangwen Zhang; Anthony Y Collmann; David Wood; Cally M Scherber; Eva Csizmadia; Odette Mariani; Cuihua Zhu; Antoine Campagne; Mehmet Toner; Sangeeta N Bhatia; Daniel Irimia; Anne Vincent-Salomon; Antoine E Karnoub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-02       Impact factor: 11.205

9.  miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.

Authors:  Hiroshi Okuda; Fei Xing; Puspa R Pandey; Sambad Sharma; Misako Watabe; Sudha K Pai; Yin-Yuan Mo; Megumi Iiizumi-Gairani; Shigeru Hirota; Yin Liu; Kerui Wu; Radhika Pochampally; Kounosuke Watabe
Journal:  Cancer Res       Date:  2013-02-05       Impact factor: 12.701

10.  Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Authors:  Sushil Kumar; Ratnesh Kumar Srivastava; Snahlata Singh; Ajeya Nandi; Gatha Thacker; Hemma Murali; Sabrina Kim; Mary Baldeon; John Tobias; Mario Andres Blanco; Rizwan Saffie; M Raza Zaidi; Satrajit Sinha; Luca Busino; Serge Y Fuchs; Rumela Chakrabarti
Journal:  Nat Cell Biol       Date:  2020-04-13       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.